Riverbend Wealth Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Riverbend Wealth Management's AMGN Position: Q3 2026 in Review
Riverbend Wealth Management reduced its Amgen (AMGN) stake by 24% in Q3 2026, selling an estimated $247K and leaving 1,991 shares worth $839K. The position accounts for 0.38% of the portfolio, ranked #70.
Riverbend Wealth Management first reported a position in AMGN in Q4 2024 and has held it in 8 quarters since. The position peaked at $945K in Q2 2026. 3,253 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.
- Riverbend Wealth Management held 1,991 shares of Amgen worth $839K as of Q3 2026.
- Riverbend Wealth Management sold 619 Amgen shares in Q3 2026, an estimated $247K.
- Amgen made up 0.38% of Riverbend Wealth Management's portfolio in Q3 2026, its #70 holding.
- Riverbend Wealth Management first reported a position in Amgen in Q4 2024 and has held it in 8 quarters since.
- Riverbend Wealth Management's Amgen position peaked at $945K in Q2 2026.
- 3,253 funds tracked by Wall St. Rank held Amgen as of Q3 2026.
Based on Riverbend Wealth Management's 13F filing for Q3 2026, filed 15 Oct 2026.